tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

KP Tissue Reports Strong Q2 2025 Results and Announces Memphis Investment

Story Highlights
  • KP Tissue Inc. reported strong Q2 2025 financial results with increased revenue and net income.
  • The company invests US$35 million in Memphis to boost efficiency and support U.S. growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
KP Tissue Reports Strong Q2 2025 Results and Announces Memphis Investment

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

KP Tissue ( (TSE:KPT) ) just unveiled an update.

KP Tissue Inc. reported strong financial results for the second quarter of 2025, with a notable increase in revenue and net income compared to the previous year. The company announced an investment of approximately US$35 million in its Memphis facility to enhance efficiency and support its growing U.S. business, which is a key growth driver despite some slowdown in U.S. revenue growth due to previous front-loaded shipments and softness in the Away-From-Home market. The company’s strategic initiatives and financial performance suggest a positive outlook for the upcoming quarter, with expectations of increased Adjusted EBITDA.

The most recent analyst rating on (TSE:KPT) stock is a Hold with a C$9.00 price target. To see the full list of analyst forecasts on KP Tissue stock, see the TSE:KPT Stock Forecast page.

Spark’s Take on TSE:KPT Stock

According to Spark, TipRanks’ AI Analyst, TSE:KPT is a Neutral.

KP Tissue’s overall stock score reflects a mix of strengths and challenges. The strong balance sheet and positive earnings call outlook are significant positives, enhancing stability and growth potential. However, profitability issues, high P/E ratio, and mixed technical indicators present cautionary elements. The attractive dividend yield provides some valuation support, but overall, the stock’s performance hinges on continued operational improvements and strategic execution amid external challenges.

To see Spark’s full report on TSE:KPT stock, click here.

More about KP Tissue

KP Tissue Inc. (KPT) is a company that holds a 12.2% interest in Kruger Products Inc., Canada’s leading manufacturer of quality tissue products for both the Consumer and Away-From-Home markets. Kruger Products is known for brands such as Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan®, and Bonterra®, and is expanding its U.S. Consumer tissue business with the White Cloud® brand and premium private label products.

Average Trading Volume: 17,821

Technical Sentiment Signal: Buy

Current Market Cap: C$94.48M

Find detailed analytics on KPT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1